Literature DB >> 32643350

"Questionable" peer review in the publishing pandemic during the time of COVID-19: implications for policy makers and stakeholders.

Francesco Chirico1, Jaime A Teixeira da Silva, Nicola Magnavita.   

Abstract

Entities:  

Year:  2020        PMID： 32643350

Source DB:  PubMed          Journal:  Croat Med J        ISSN： 0353-9504            Impact factor:   1.351


× No keyword cloud information.
  7 in total

1.  Research ethics committees: A forum where scientists, editors, and policymakers can cooperate during pandemics.

Authors:  Francesco Chirico; Katrina A Bramstedt
Journal:  Med Sci Law       Date:  2022-01-25       Impact factor: 2.051

Review 2.  SARS/MERS/SARS-CoV-2 Outbreaks and Burnout Syndrome among Healthcare Workers. An Umbrella Systematic Review.

Authors:  Nicola Magnavita; Francesco Chirico; Sergio Garbarino; Nicola Luigi Bragazzi; Emiliano Santacroce; Salvatore Zaffina
Journal:  Int J Environ Res Public Health       Date:  2021-04-20       Impact factor: 3.390

3.  Declaration of conflict of interest for reviewers in time of COVID-19 should be mandatory.

Authors:  Francesco Chirico; Nicola Luigi Bragazzi
Journal:  Perspect Clin Res       Date:  2021-01-19

4.  Publication practices during the COVID-19 pandemic: Expedited publishing or simply an early bird effect?

Authors:  Yulia V Sevryugina; Andrew J Dicks
Journal:  Learn Publ       Date:  2022-06-30

5.  Optimizing peer review to minimize the risk of retracting COVID-19-related literature.

Authors:  Jaime A Teixeira da Silva; Helmar Bornemann-Cimenti; Panagiotis Tsigaris
Journal:  Med Health Care Philos       Date:  2020-11-20

6.  Will evidence-based medicine be another casualty of COVID-19?

Authors:  Roger Watson; Niall McCrae
Journal:  J Adv Nurs       Date:  2020-10-15       Impact factor: 3.057

7.  Paper mills and on-demand publishing: Risks to the integrity of journal indexing and metrics.

Authors:  Jaime A Teixeira da Silva
Journal:  Med J Armed Forces India       Date:  2020-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.